Permeability of the WT and Mutant P2X7 Receptors to Organic Cations
| Receptors . | I (pA/pF) KR . | RP (mV) NMDG+ . | . | RP (mV) NMDG+-KR . | . | RP (mV) NMEA+-KR . | . | |||
|---|---|---|---|---|---|---|---|---|---|---|
| WT | 122 ± 8 | −66.9 ± 0.2 | −45.4 ± 2.5b | −36.5 ± 0.3 | −24.6 ± 0.8b | −20.0 ± 0.5 | −4.6 ± 1.0b | |||
| T15A | 30 ± 3a | −68.9 ± 0.4 | −53.8 ± 1.2b | −36.2 ± 0.8 | −36.5 ± 0.5 | −18.9 ± 0.7 | −17.1 ± 1.1 | |||
| T15E | 94 ± 10 | −54.9 ± 1.2a | −53.7 ± 1.5 | −22.4 ± 0.7a | −21.8 ± 0.9 | −14.8 ± 0.7a | −12.0 ± 0.5 | |||
| T15K | 187 ± 45 | −35.5 ± 0.9a | −36.7 ± 0.6 | −19.7 ± 0.6a | −17.1 ± 0.6 | −14.9 ± 0.5a | −11.0 ± 0.6b | |||
| T15W | 142 ± 11 | −52.6 ± 0.9a | −47.4 ± 1.3 | −23.0 ± 0.3a | −22.4 ± 0.5 | −16.4 ± 0.8a | −14.4 ± 0.7 | |||
| T15V | 33 ± 4a | −65.3 ± 0.6 | −48.5 ± 1.9b | −36.1 ± 0.3 | −32.1 ± 0.6b | −20.6 ± 0.4 | −17.5 ± 0.5b | |||
| T15S | 47 ± 8a | −65.8 ± 0.3 | −53.4 ± 0.8b | −36.6 ± 0.2 | −31.7 ± 1.1b | −20.9 ± 0.4 | −12.9 ± 1.7b | |||
| K17A | 250 ± 25a | −65.5 ± 0.4 | −45.2 ± 3.6b | −35.3 ± 0.2a | −23.9 ± 1b | −18.2 ± 0.6 | −7.4 ± 0.4b | |||
| Δ18 | 180 ± 21 | −50.3 ± 0.9a | −47.9 ± 1.2 | −28.1 ± 0.6a | −28.1 ± 1.1 | −17.2 ± 0.4 | −15.6 ± 1.1 | |||
| Receptors . | I (pA/pF) KR . | RP (mV) NMDG+ . | . | RP (mV) NMDG+-KR . | . | RP (mV) NMEA+-KR . | . | |||
|---|---|---|---|---|---|---|---|---|---|---|
| WT | 122 ± 8 | −66.9 ± 0.2 | −45.4 ± 2.5b | −36.5 ± 0.3 | −24.6 ± 0.8b | −20.0 ± 0.5 | −4.6 ± 1.0b | |||
| T15A | 30 ± 3a | −68.9 ± 0.4 | −53.8 ± 1.2b | −36.2 ± 0.8 | −36.5 ± 0.5 | −18.9 ± 0.7 | −17.1 ± 1.1 | |||
| T15E | 94 ± 10 | −54.9 ± 1.2a | −53.7 ± 1.5 | −22.4 ± 0.7a | −21.8 ± 0.9 | −14.8 ± 0.7a | −12.0 ± 0.5 | |||
| T15K | 187 ± 45 | −35.5 ± 0.9a | −36.7 ± 0.6 | −19.7 ± 0.6a | −17.1 ± 0.6 | −14.9 ± 0.5a | −11.0 ± 0.6b | |||
| T15W | 142 ± 11 | −52.6 ± 0.9a | −47.4 ± 1.3 | −23.0 ± 0.3a | −22.4 ± 0.5 | −16.4 ± 0.8a | −14.4 ± 0.7 | |||
| T15V | 33 ± 4a | −65.3 ± 0.6 | −48.5 ± 1.9b | −36.1 ± 0.3 | −32.1 ± 0.6b | −20.6 ± 0.4 | −17.5 ± 0.5b | |||
| T15S | 47 ± 8a | −65.8 ± 0.3 | −53.4 ± 0.8b | −36.6 ± 0.2 | −31.7 ± 1.1b | −20.9 ± 0.4 | −12.9 ± 1.7b | |||
| K17A | 250 ± 25a | −65.5 ± 0.4 | −45.2 ± 3.6b | −35.3 ± 0.2a | −23.9 ± 1b | −18.2 ± 0.6 | −7.4 ± 0.4b | |||
| Δ18 | 180 ± 21 | −50.3 ± 0.9a | −47.9 ± 1.2 | −28.1 ± 0.6a | −28.1 ± 1.1 | −17.2 ± 0.4 | −15.6 ± 1.1 | |||
Peak amplitude of current (I) reached during a 4-s agonist application and reversal potential (RP) for WT and mutant receptors bathed in KR, NMDG+, NMDG+-KR, or NMEA+-KR solutions at the beginning (0.75 s; left columns) and end (right columns) of a 40-s application of 100 μM BzATP. Data shown are mean ± SEM values from at least six replicates per mutant.
Significant differences between WT and mutant receptors during a 40-s agonist application; P < 0.01.
Significant shifts in the reversal potential during a 40-s agonist application; P < 0.01.